Sign in
4

Changes in Ownership

Annexon, Inc. Filed Acc 0001567619-21-005222

Options or other derivatives

  • EVP & Chief Scientific Officer acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Yednock Ted EVP & Chief Scientific Officer 2021-02-25 Grant or award · Stock Option (Right to Buy) +115,000 115,000 D: show line 1 in the form
Loading xslF345X03/doc1.xml…